Cubist Pharmaceuticals, Inc. today announced that it has completed the previously announced acquisition of Adolor Corporation for an aggregate upfront cash consideration of approximately $221 million.
134649
Cubist Pharmaceuticals completes acquisition of Adolor Corporation
168507
PharMerica signs asset purchase agreement to acquire Chem Rx Corporation
117438
FedEx completes acquisition of TATEX
148121
NeuroSearch has completed sale of laboratory equipment and office furniture
70781
Nike completes sale of Bauer Hockey for $200 million cash
32474
GlaxoSmithKline to acquire Sirtris Pharmaceuticals
115014
Pfizer buying FoldRx for undisclosed amount
108775
Pharmaceutical company sealed
150408
Sanofi-Aventis completes buyout of Genzyme
23626
Dow Chemical Company completes sale of acrylic acid, esters and speciality latex assets
60006
ON semi completes acquisition
38003
ConvaTec completes acquisition of Unomedical
115525
IMedicor signs agreement with Access Pharmaceuticals for the North American commercial launch of MuGard
19074
Vizrt buys LiberoVision
49776
Uni-Select completes purchase of FinishMaster
4209
Iconix brand Group completes acquisition of Umbro
153366
Aker Solutions acquires fabrication business